Miguel López-Dupla
- Virology top 5%
- HIV Research and Treatment 12
- Emergency Medicine top 5%
- HIV-related health complications and treatments 15
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 7
- COVID-19 Clinical Research Studies 4
- Antifungal resistance and susceptibility 4
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research 6
-
- Liver Disease Diagnosis and Treatment 5
- Adipokines, Inflammation, and Metabolic Diseases 4
- Co-authors
- Francesc VidalCristóbal RichartPeré DomingoJoaquim PeraireConsuelo ViladésMontserrat OlonaTeresa AuguetMontserrat Broch
- Partner nations
- SpainUnited StatesCanada
In The Last Decade
Miguel López-Dupla
59 papers receiving 879 citations
Peers
Comparison fields: 5 of 85
- Virology 209
- Emergency Medicine 200
- Infectious Diseases 262
- Applied Microbiology and Biotechnology 23
- Rheumatology 159
Countries citing papers authored by Miguel López-Dupla
This map shows the geographic impact of Miguel López-Dupla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel López-Dupla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel López-Dupla more than expected).
Fields of papers citing papers by Miguel López-Dupla
This network shows the impact of papers produced by Miguel López-Dupla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel López-Dupla. The network helps show where Miguel López-Dupla may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miguel López-Dupla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2022 | 13 | |
| 3 | 2019 | 5 | |
| 4 | 2018 | 12 | |
| 5 | 2018 | 20 | |
| 6 | 2017 | 27 | |
| 7 | 2016 | 23 | |
| 8 | 2015 | 5 | |
| 9 | 2013 | 8 | |
| 10 | 2012 | 22 | |
| 11 | 2011 | 14 | |
| 12 | 2011 | 18 | |
| 13 | 2010 | 9 | |
| 14 | 2010 | 7 | |
| 15 | 2009 | 26 | |
| 16 | 2009 | 12 | |
| 17 | 2008 | 20 | |
| 18 | 2007 | 24 | |
| 19 | 2006 | 29 | |
| 20 | 2005 | 34 |
About Miguel López-Dupla
Miguel López-Dupla is a scholar working on Virology, Emergency Medicine and Infectious Diseases, having authored 59 papers that have together received 904 indexed citations. Recurring topics across this work include HIV-related health complications and treatments (15 papers), HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (7 papers), Systemic Lupus Erythematosus Research (6 papers), Liver Disease Diagnosis and Treatment (5 papers), COVID-19 Clinical Research Studies (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Antifungal resistance and susceptibility (4 papers). The work is most often cited by research in Virology (209 citations), Emergency Medicine (200 citations) and Infectious Diseases (262 citations). Miguel López-Dupla has collaborated with scholars based in Spain, United States and Canada. Frequent co-authors include Francesc Vidal, Cristóbal Richart, Peré Domingo, Joaquim Peraire, Consuelo Viladés, Montserrat Olona, Teresa Auguet, Montserrat Broch, Carmen Aguilar and Munther A. Khamashta. Their work appears in journals such as PLoS ONE, Cancer and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.